Oxford Nanopore Technologies’ (ONT) “Buy” Rating Reaffirmed at Berenberg Bank

Berenberg Bank reissued their buy rating on shares of Oxford Nanopore Technologies (LON:ONT) in a research report sent to investors on Wednesday morning, LSE.Co.UK reports. They currently have a GBX 350 ($4.36) target price on the stock.

Separately, Citigroup reaffirmed a buy rating and set a GBX 210 ($2.61) price objective on shares of Oxford Nanopore Technologies in a research report on Friday, April 12th. Five research analysts have rated the stock with a buy rating, According to MarketBeat, the stock presently has an average rating of Buy and an average target price of GBX 303.75 ($3.78).

Oxford Nanopore Technologies Stock Down 3.1 %

LON:ONT opened at GBX 95.80 ($1.19) on Wednesday. Oxford Nanopore Technologies has a 1 year low of GBX 92.20 ($1.15) and a 1 year high of GBX 279 ($3.47). The company has a current ratio of 5.01, a quick ratio of 6.01 and a debt-to-equity ratio of 6.47. The stock has a market cap of £823.84 million, a price-to-earnings ratio of -659.33 and a beta of 0.59. The stock has a 50-day moving average price of GBX 132.09 and a two-hundred day moving average price of GBX 169.04.

Insider Transactions at Oxford Nanopore Technologies

In other news, insider Gurdial (Gordon) Sanghera acquired 39,196 shares of Oxford Nanopore Technologies stock in a transaction dated Wednesday, March 6th. The stock was bought at an average cost of GBX 127 ($1.58) per share, with a total value of £49,778.92 ($61,968.03). Insiders bought 39,421 shares of company stock valued at $5,007,852 over the last three months. Company insiders own 30.07% of the company’s stock.

About Oxford Nanopore Technologies

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.